143 related articles for article (PubMed ID: 30134817)
1. Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness.
Monaghan SF; Banerjee D; Chung CS; Lomas-Neira J; Cygan KJ; Rhine CL; Fairbrother WG; Heffernan DS; Levy MM; Cioffi WG; Ayala A
Mol Med; 2018 Jun; 24(1):32. PubMed ID: 30134817
[TBL] [Abstract][Full Text] [Related]
2. Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality.
Lange A; Sundén-Cullberg J; Magnuson A; Hultgren O
PLoS One; 2017; 12(1):e0169176. PubMed ID: 28056053
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies.
Gorgulho J; Roderburg C; Heymann F; Schulze-Hagen M; Beier F; Vucur M; Kather JN; Laleh NG; Tacke F; Brümmendorf TH; Luedde T; Loosen SH
Int J Cancer; 2021 Sep; 149(5):1189-1198. PubMed ID: 33890289
[TBL] [Abstract][Full Text] [Related]
4. Application of monoclonal antibodies in a sandwich enzyme-linked immunosorbent assay for identification and detection of soluble human B and T lymphocyte attenuator.
Wang X; Zhu G; Huang Z; Cao L; Chen Y; Wang Q; Zhang X
Hybridoma (Larchmt); 2012 Dec; 31(6):417-23. PubMed ID: 23244320
[TBL] [Abstract][Full Text] [Related]
5. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
[TBL] [Abstract][Full Text] [Related]
6. Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis.
Lange A; Cajander S; Magnuson A; Strålin K; Hultgren O
PLoS One; 2022; 17(3):e0265818. PubMed ID: 35312715
[TBL] [Abstract][Full Text] [Related]
7. Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model.
Zhou G; Wang D; Liu D; Qi D; Liu Z
Clin Lab; 2016 Dec; 62(12):2367-2377. PubMed ID: 28164546
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
9. BTLA as a biomarker and mediator of sepsis-induced immunosuppression.
Sherwood ER; Hotchkiss RS
Crit Care; 2013 Dec; 17(6):1022. PubMed ID: 24321139
[TBL] [Abstract][Full Text] [Related]
10. Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study.
Shao R; Li CS; Fang Y; Zhao L; Hang C
Crit Care; 2015 Aug; 19(1):308. PubMed ID: 26329820
[TBL] [Abstract][Full Text] [Related]
11. B and T lymphocyte attenuator inhibits antigen-induced eosinophil recruitment into the airways.
Tamachi T; Watanabe N; Oya Y; Kagami S; Hirose K; Saito Y; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2007; 143 Suppl 1():50-5. PubMed ID: 17541277
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.
Cheng T; Bai J; Chung CS; Chen Y; Biron BM; Ayala A
Shock; 2016 Jan; 45(1):40-9. PubMed ID: 26674453
[TBL] [Abstract][Full Text] [Related]
13. AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo.
Han L; Wang W; Lu J; Kong F; Ma G; Zhu Y; Zhao D; Zhu J; Shuai W; Zhou Q; Chen P; Ye L; Tao J; Ahmad S; Li F; Sun J
Cancer Lett; 2014 Nov; 354(2):398-406. PubMed ID: 25153350
[TBL] [Abstract][Full Text] [Related]
14. BTLA biology in cancer: from bench discoveries to clinical potentials.
Andrzejczak A; Karabon L
Biomark Res; 2024 Jan; 12(1):8. PubMed ID: 38233898
[TBL] [Abstract][Full Text] [Related]
15. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
[TBL] [Abstract][Full Text] [Related]
16. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.
Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q
Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630
[TBL] [Abstract][Full Text] [Related]
17. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin on the function of splenic CD4
Kong B; Wang X; Yang W; Zhao X; Zhang R; Wang Y
Immunol Res; 2018 Jun; 66(3):355-366. PubMed ID: 29752615
[TBL] [Abstract][Full Text] [Related]
19. The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases.
Deng Z; Zheng Y; Cai P; Zheng Z
Front Immunol; 2021; 12():635623. PubMed ID: 34163466
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression.
Wakeley ME; Armstead BE; Gray CC; Tindal EW; Heffernan DS; Chung CS; Ayala A
Front Med (Lausanne); 2023; 10():1176602. PubMed ID: 37305124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
